中药概念股早盘走强，相关ETF涨约2%

Group 1 - The core viewpoint of the news is that traditional Chinese medicine (TCM) concept stocks are experiencing a strong performance in the market, with notable increases in companies like Tongrentang and Zhaoli Pharmaceutical, both rising over 2% [1] - The ETF tracking the CSI Traditional Chinese Medicine Index has also seen an approximate increase of 2% [1] - The CSI Traditional Chinese Medicine Index includes listed companies involved in the production and sales of TCM, reflecting the overall performance of TCM concept stocks [2] Group 2 - Analysts suggest that the aging population and increasing health awareness among residents are the primary long-term drivers for consumer TCM [2] - The TCM industry is characterized by a long industrial chain and the "preventive-treatment-nurturing" model, which is expected to be more fully realized [2] - There is optimism regarding leading TCM companies with advantages in formulas, raw materials, and brand recognition, as well as those extending their industrial chains into consumer TCM [2]